Impact of cilazapril on fibrinolytic system in hypertensive patients

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
Izzet Hosgor, Sarfraz Ahmad

Abstract

Impaired fibrinolysis is associated with thromboembolic complications in hypertensive patients. Cardiovascular morbidity/mortality rates have been reported high even after lowering the elevated blood pressure with antihypertensive drugs. We investigated the effects of clinically used dosages of cilazapril on the fibrinolytic system in hypertensive patients. The present study was performed among 30 hypertensive patients (22 women, eight men), who received 2.5-5.0 mg cilazapril daily for 1 month. Before and after the cilazapril treatment, patients' venous blood was drawn for fibrinolytic tests. The fibrinolytic activity was examined utilizing the euglobulin clot lysis time and fibrin plate methods. Using the fibrin plate method, as compared with the pretreatment group, we observed a 57% increased activity in the hypertensive patients receiving cilazapril (P < 0.001). When assessed by the euglobulin clot lysis time method, the activity due to cilazapril treatment was found to be relatively low, although highly significant (approximately 20%, P < 0.001). Changes in fibrinolytic activity were observed in 23 (77%) hypertensive patients after cilazapril treatment; however, their blood pressure remained normal. The remaining seven pati...Continue Reading

References

Apr 1, 1991·Journal of Internal Medicine·J H JanssonT K Nilsson
Mar 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·J A OlsonM K Raizada
Jul 5, 1990·The New England Journal of Medicine·J A PanzaS E Epstein
Nov 11, 1989·BMJ : British Medical Journal·P H HeldC D Furberg
Dec 26, 1989·The American Journal of Medicine·C H KleinbloesemU W Wiegand
May 1, 1989·The American Journal of Physiology·J M PatelM K Raizada
Feb 27, 1984·The American Journal of Medicine·W P Castelli
Dec 1, 1994·American Heart Journal·L LindH Lithell
Jan 15, 1995·Annals of Internal Medicine·B L KasiskeT A Louis
Mar 6, 1997·The American Journal of Cardiology·D E Vaughan

❮ Previous
Next ❯

Citations

Feb 5, 2019·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Annabella Braschi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.